Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Admission uric acid levels and length of expectant management in preterm preeclampsia

Journal of Perinatology volume 32, pages 757–762 (2012)Cite this article

Subjects

Abstract

Objective:

Uric acid is known to be elevated in preeclampsia. We sought to determine if uric acid levels on admission correlate with the length of expectant management in preterm patients with preeclampsia.

Study Design:

A retrospective chart review was conducted on singleton preeclamptic pregnancies delivered between 24 0/7 and 37 0/7 weeks’ gestation at Tufts Medical Center between January 2005 and December 2007. Patients with a multiple gestation and those transferred or discharged before delivery were excluded. Data regarding signs and symptoms of preeclampsia, laboratory values, pregnancy complications and outcome were abstracted from the medical records. Correlation between admission uric acid level and days of expectant management was assessed. The relative risk (RR) was used to estimate the effect of uric acid levels on expectant management length >7 days. Mantel–Haenszel χ2 values were used to construct 95% confidence intervals (CIs) around the RR.

Result:

Four hundred seventy-one charts were reviewed. Of these, 190 met inclusion criteria. In all, 55 patients (28.9%) were managed expectantly for >1 week. Admission uric acid level correlated with days of expectant management (P<0.0001). Uric acid levels at admission were categorized as ⩽4.0 mg dl–1 (low uric acid level), 4.1 to 6.0 mg dl–1 (medium) and ⩾6.1 mg dl–1 (high). Relative to women with high uric acid levels at admission, we observed a sevenfold higher rate of extending expectant management for >1 week among women with low uric acid level (7.0; 95% CI: 3.34 to 14.68). Women with medium uric acid levels at admission also had a higher likelihood of prolonging pregnancy relative to women with high uric acid levels (RR: 2.81; 95% CI: 1.32 to 5.96) (P-value for trend <0.0001).

Conclusion:

Admission uric acid levels correlate with the length of expectant management in preterm patients with preeclampsia. Pregnancy prolongation for >1 week is significantly more likely in patients with low and medium uric acid levels at the time of admission. Uric acid levels may be helpful in assessing disease severity and counseling preeclamptic patients regarding likelihood of extended expectant management.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

Article 16 February 2023

Evdokia Dimitriadis, Daniel L. Rolnik, … Ellen Menkhorst

References

  1. Haig A . Uric acid as a factor in the causation of disease. A Contribution to the Pathology of High Blood Pressure, Headache, Epilepsy, Mental Depression, Paroxysmal Hemoglobinuria and Anemia, Bright's Disease, Diabetes, Gout, Rheumatism, and Other Disorders. J and A Churchill: London, 1897.

    Google Scholar 

  2. Bainbridge SA, Roberts JM . Uric acid as a pathogenic factor in preeclampsia. Placenta 2008; 29: S67–S72, Supplement A, Trophoblast Research, Vol. 22.

    Article  Google Scholar 

  3. Powers RW, Bodnar LM, Ness RB, Cooper KM, Gallaher MJ, Frank MP et al. Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery. Am J Obstet Gynecol 2006; 194: 160e1–160e8.

    Article  Google Scholar 

  4. Dekker GA, Sibai BM . Early detection of preeclampsia. Am J Obstet Gynecol 1991; 165: 160–172.

    Article  CAS  Google Scholar 

  5. Conde-Agudelo A, Lede R, Belizan J . Evaluation of methods used in the prediction of hypertensive diseases of pregnancy. Obstet Gynecol Surv 1994; 49: 210–222.

    Article  CAS  Google Scholar 

  6. Lim KH, Friedman SA, Ecker JL, Kao L, Kilpatrick SJ . The clinical utility of serum uric acid measurements in hypertensive diseases of pregnancy. Am J Obstet Gynecol 1998; 178: 1067–1071.

    Article  CAS  Google Scholar 

  7. Lancet M, Fisher IL . The value of blood uric acid values in toxaemia of pregnancy. J Obstet Gynaecol Br Emp 1956; 63: 116–119.

    Article  CAS  Google Scholar 

  8. McFarlane CN . An evaluation of the serum uric acid level in pregnancy. J Obstet Gynaecol Br Commonw 1963; 70: 63–68.

    Article  CAS  Google Scholar 

  9. Redman CW, Beilin LJ, Bonnar J, Wilkinson RH . Plasma-urate measurements in predicting fetal death in hypertensive pregnancy. Lancet 1976; 1: 1370–1373.

    Article  CAS  Google Scholar 

  10. Liedholm H, Montan S, Aberg A . Risk grouping of 113 patients with hypertensive disorders during pregnancy, with respect to serum urate, proteinuria, and time of onset of hypertension. Acta Obstet Gynecol Scand Suppl 1984; 118: 43–48.

    Article  CAS  Google Scholar 

  11. Martin Jr JN, May WL, Megann EF, Terrone DA, Rinehart BK, Blake P-G . Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol 1999; 180: 1407–1414.

    Article  Google Scholar 

  12. Wakwe VC, Abudu OO . Estimation of plasma uric acid in pregnancy induced hypertension (PIH). Is the test still relevant? Afr J Med Med Sci 1999; 28: 155–158.

    CAS  PubMed  Google Scholar 

  13. D’Anna R, Baviera G, Scilipoti A, Leonardi I, Leo R . The clinical utility of serum uric acid measurements in pre-eclampsia and transient hypertension in pregnancy. Panminerva Medica 2000; 42: 101–103.

    PubMed  Google Scholar 

  14. Roberts JM, Bodnar LM, Lain KY, Hubel CA, Markovic N, Ness RB et al. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension 2005; 46: 1263–1269.

    Article  CAS  Google Scholar 

  15. Thangaratinam S, Ismail KMK, Sharp S, Coomarasamy A, Khan KS . Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. BJOG 2006; 113: 369–378.

    Article  CAS  Google Scholar 

  16. Gupta A, Kaliaperumal S, Setia S, Suchi ST, Rao VA . Retinopathy in preeclampsia: association with birthweight and uric acid level. Retina 2008; 28: 1104–1110.

    Article  Google Scholar 

  17. Koopmans CM, van Pampus MG, Groen H, Aarnoudse JG, van den Berg PP, Mol BW . Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis. Eur J Obstet Gynecol Reprod Biol 2009; 146: 8–14.

    Article  CAS  Google Scholar 

  18. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin No. 33. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002; 99: 159–167.

    Google Scholar 

  19. Klienbaum DG, Kupper LL, Morgenstern H . Epidemiologic Research. John Wiley and Sons: NY, 1982.

    Google Scholar 

  20. Armitage P, Berry G, Matthews JNS . Statistical Methods in Medical Research, 4th edn. Blackwell Science: London, 2002.

    Book  Google Scholar 

  21. Kang DH, Finch J, Nakagawa T, Karumanchi SA, Kanellis J, Granger J et al. Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link. J Hypertens 2004; 22: 229–235.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Tufts University School of Medicine, Tufts Medical Center, Boston, MA, USA

    A C Urato, B Bond, S D Craigo, E R Norwitz & W C Strohsnitter

  2. Tufts Clinical and Translational Science Institute, Tufts University, Medford, MA, USA

    J K Paulus

Authors
  1. A C Urato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B Bond
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S D Craigo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E R Norwitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J K Paulus
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W C Strohsnitter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A C Urato.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

This study was presented at SMFM 2009 Annual Meeting, San Diego, CA, USA.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Urato, A., Bond, B., Craigo, S. et al. Admission uric acid levels and length of expectant management in preterm preeclampsia. J Perinatol 32, 757–762 (2012). https://doi.org/10.1038/jp.2011.187

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2011.187

Keywords

This article is cited by

Search

Advanced search

Quick links